PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
Translating Science. Transforming Lives.
View Our Pipeline
PTC STRIVE Awards Program
PTC is proud to announce the recipients of the 2016 STRIVE for DMD awards.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View all latest news